Previous studies have indicated COL5A1’s role in gastric cancer progression through acting as a ceRNA for miR-137-3p to promote FSTL1 expression (52) and its association with ovarian cancer progression, taxol resistance, and immune cell infiltration in the tumor environment (53). Here, COL5A1 is linked to ovarian carcinoma.